Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%

MT Newswires Live

Dec 11, 2025

Bioxyne (ASX:BXN) is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.

Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.

The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.

Bioxyne's shares rose 3% in recent trading on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2590356926"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2590356926\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2590356926?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-11 12:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590356926","market":"sh","top_or_hot":-1,"title":"Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%","media":"MT Newswires Live","content":"<html><body><p> Bioxyne (ASX:BXN) is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.</p><p>Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.</p><p>The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.</p><p>Bioxyne's shares rose 3% in recent trading on Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-11 12:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Bioxyne (ASX:BXN) is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.</p><p>Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.</p><p>The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.</p><p>Bioxyne's shares rose 3% in recent trading on Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7111","symbol_name":"个人用品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2590356926","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590356926","pubTimestamp":1765428972,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bioxyne  is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.Bioxyne's shares rose 3% in recent trading on Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7111":"个人用品","BXN.AU":"BIOXYNE LTD","BK7508":"医药生物股"},"translate_title":"Bioxyne与Remidose签订制造和供应协议，进入哥斯达黎加、巴拿马药用大麻市场；股价上涨3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BXN.AU":1},"content_text":"Bioxyne (ASX:BXN) is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.Bioxyne's shares rose 3% in recent trading on Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}